Skip to main content
The new Teacher Workspace is here. Your first 3 assignments are free. Try it →

Maintenance therapy

Maintenance therapy is the ongoing, long-term drug treatment used to keep a chronic condition stable, especially epilepsy, after seizures are initially controlled. In Intro to Pharmacology, it means regular antiepileptic dosing to prevent breakthrough seizures.

Last updated July 2026

What is maintenance therapy?

Maintenance therapy in Intro to Pharmacology is the long-term medication plan used after a patient has already been stabilized, most often after seizure control in epilepsy. The goal is not to stop an active emergency, but to keep the condition quiet so seizures do not come back.

For epilepsy, maintenance therapy usually means taking an antiepileptic drug consistently at a dose that keeps blood levels steady. That steady level matters because seizures can return when the drug level drops too low, such as after missed doses, vomiting, drug interactions, or changes in metabolism. This is why maintenance therapy is tied to adherence and regular follow-up.

The medications used for maintenance are chosen based on seizure type, side effects, patient age, other health conditions, and how the drug is handled in the body. Some AEDs need to be adjusted slowly, because the wrong dose can cause toxicity or fail to control seizures. A patient may also need a different drug if one causes too much sedation, dizziness, rash, or other adverse effects.

A big pharmacology idea here is balance. You want enough drug to raise the seizure threshold and prevent recurrence, but not so much that the patient gets avoidable side effects. That is why maintenance therapy is often paired with titration at the start, followed by a stable dosing phase once the best dose is found.

In practice, maintenance therapy is the part of treatment where pharmacokinetics really show up. Drug absorption, metabolism, and elimination affect how long a medication stays active, and some AEDs also interact with liver enzymes. If a drug is cleared faster than expected, the maintenance dose may need adjustment. If another drug is added, the maintenance plan may need to change again.

Why maintenance therapy matters in Intro to Pharmacology

Maintenance therapy matters because epilepsy management is not just about stopping a single seizure, it is about preventing the next one. In pharmacology, that makes it a good example of chronic drug therapy where the dosing plan matters as much as the drug choice.

This term also connects the course’s big ideas about mechanism, dosing, and adverse effects. You have to know why a drug works, but you also have to know how often it is taken, how long it stays active, and what happens if the patient misses doses. That is where maintenance therapy becomes more than a label. It explains why a drug that worked well in the hospital can fail later if the home regimen is inconsistent.

It also shows up in medication counseling. A patient on AED maintenance therapy needs clear instructions about adherence, side effects, and follow-up visits. If a quiz or case asks why breakthrough seizures happen after a skipped dose, this term is part of the answer.

In a broader pharmacology sense, maintenance therapy is a useful contrast with acute treatment. It helps you sort drugs by purpose, not just by class name. That is a skill you use constantly in this course when you match a condition to the right treatment strategy.

Keep studying Intro to Pharmacology Unit 5

Official unit cheatsheet

open one-pager

How maintenance therapy connects across the course

Antiepileptic drugs (AEDs)

Maintenance therapy depends on AEDs because these are the drugs used to keep seizure activity under control over time. The term tells you the treatment plan, while AEDs tell you the medication class. In a case question, you often need both, because the therapy may involve choosing one AED or combining several based on seizure type and tolerance.

Titration

Titration usually happens before maintenance therapy settles in. The dose is adjusted gradually until seizure control is reached without too many side effects. Once the right dose is found, the patient moves into a maintenance phase, where the goal is to keep that dose steady unless symptoms or labs suggest a change.

cyp450 interactions

Some antiepileptic drugs interact with CYP450 enzymes, which can change how fast they are broken down. That can make maintenance therapy harder to manage because the drug level may rise too high or fall too low. When another medication is added, this is one of the first things to check in an epilepsy case.

Seizure threshold

Maintenance therapy works by helping keep the seizure threshold high enough that normal brain activity does not tip into a seizure. The term connects the drug plan to the brain’s excitability. If a patient’s threshold drops because of missed doses, sleep loss, or an interaction, breakthrough seizures become more likely.

Is maintenance therapy on the Intro to Pharmacology exam?

A quiz or case question may describe a patient whose seizures stopped after the first treatment phase and then ask what happens next. The answer you are looking for is the long-term medication plan, not emergency seizure stopping. You may also have to explain why missed doses matter, why side effects can force a dose change, or why a drug interaction lowers seizure control.

In short-answer items, use maintenance therapy to connect the treatment goal to steady AED levels, adherence, and follow-up monitoring. In case studies, look for clues like a chronic epilepsy diagnosis, a stable regimen, or breakthrough seizures after nonadherence. If the prompt asks why the patient is still taking medicine even though they have not had a recent seizure, maintenance therapy is the right concept.

Maintenance therapy vs Titration

Titration is the process of adjusting a drug dose upward or downward to find the right amount. Maintenance therapy is what comes after that, when the dose is kept stable to prevent seizures long term. If a question is about changing the dose, think titration. If it is about staying on a steady regimen, think maintenance therapy.

Key things to remember about maintenance therapy

  • Maintenance therapy is the long-term drug phase that keeps epilepsy under control after the patient is stabilized.

  • The main goal is to prevent breakthrough seizures while keeping side effects as low as possible.

  • Missed doses can drop the drug level enough to trigger seizures again, so adherence matters a lot.

  • Maintenance therapy often uses AEDs at a steady dose, but the dose can change if the patient’s response, metabolism, or interactions change.

  • In pharmacology, this term helps you separate acute seizure treatment from chronic seizure prevention.

Frequently asked questions about maintenance therapy

What is maintenance therapy in Intro to Pharmacology?

Maintenance therapy is the ongoing use of medication to keep a chronic condition controlled after the initial problem is stabilized. In epilepsy, that usually means regular antiepileptic drug dosing to prevent more seizures. The focus is steady control, not emergency treatment.

Is maintenance therapy the same as titration?

No. Titration is the step where the dose is adjusted to find the best level for control and tolerability. Maintenance therapy starts after that, when the patient stays on a steady dose to prevent seizures. They often happen back to back, but they are not the same stage.

Why do missed doses matter so much in maintenance therapy?

Because many antiepileptic drugs need a fairly steady blood level to work well. If the level drops too far, the seizure threshold can fall and a breakthrough seizure can happen. That is why adherence is a major part of seizure management.

What drugs are used for maintenance therapy in epilepsy?

Maintenance therapy uses antiepileptic drugs, but the exact medication depends on the seizure type, side effect risk, and drug interactions. Some drugs are better for certain seizure patterns than others, and some need extra monitoring because of CYP450 effects or other pharmacokinetic issues.